Don`t forget or rule out Chia topping back up to 15% after he was diluted due to last placement.
One thing we can rule out over the volume that`s gone through is that it`s not all retail. When someone supplies us Broker data, this should confirm this........
Hows this just for one trade in the close! 800,000 shares worth $48,800!
So IMO we have corporate/institutional buying, whether it`s related to our lithium project in U.S or the Bull project in W.A (which I`m tipping) or the exceptional Yellow Cat Uranium results in W.A will remain to be seen.
Column 1 Column 2 Column 3 Column 4 1 4:10:05 PM 0.061 800,000 48,800.000
Also don`t forget about the 24,088,000 unlisted options issued to the broker in lieu of payment for the last placement at .028c The exercise price for their unlisted options is .056 cents, so they are IN THE MONEY. More capital for the Company ($1,348,928) if exercised prior to November 30th 2022
Food for thought anyway...........
- Forums
- ASX - By Stock
- ASN
- Ann: Anson Commences Li Battery Cell Performance Testing
Ann: Anson Commences Li Battery Cell Performance Testing, page-41
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ASN (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.7¢ |
Change
-0.001(1.47%) |
Mkt cap ! $92.77M |
Open | High | Low | Value | Volume |
6.8¢ | 6.9¢ | 6.6¢ | $140.8K | 2.096M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 255554 | 6.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 115643 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 155555 | 0.067 |
4 | 939410 | 0.066 |
7 | 767516 | 0.065 |
2 | 220000 | 0.064 |
2 | 340000 | 0.063 |
Price($) | Vol. | No. |
---|---|---|
0.069 | 115643 | 3 |
0.070 | 19745 | 1 |
0.071 | 3000 | 1 |
0.072 | 57234 | 2 |
0.073 | 37777 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
ASN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online